Atomo Diagnostics Ltd has released a press release.
Update on Indicated Pascal Supply for FebriDx
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Atomo Diagnostics
- Successful Placement from Share Purchase Plan Shortfall
- Atomo secures order for Pascal worth US$410,000 from Lumos
- Share Purchase Plan Results & Tranche 2 Placement Approved
- Atomo secures Australian order for supply of HIV Self-Tests
- Share Purchase Plan Prospectus
Later from Atomo Diagnostics
- 2025 Appendix 4E and Annual Report
- Exclusive Licence for a Novel Liver Function Test on Pascal
- Quarterly Activities/Appendix 4C Cash Flow Report
- Atomo Secures a Significant Order for HIV Self-Test
- Appendix 4D and Half Year Report ended 31 Dec 2025
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics